The Prohibitin-Binding Compound Fluorizoline Activates the Integrated Stress Response through the eIF2α Kinase HRI.
ER-stress
HRI
ISR
apoptosis
fluorizoline
mitochondrial-stress
prohibitin
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 Apr 2023
29 Apr 2023
Historique:
received:
24
03
2023
revised:
24
04
2023
accepted:
27
04
2023
medline:
15
5
2023
pubmed:
13
5
2023
entrez:
13
5
2023
Statut:
epublish
Résumé
Fluorizoline is a synthetic molecule that induces apoptosis, by selectively targeting prohibitins (PHBs), through induction of the BH3-only protein NOXA. This induction is transcriptionally regulated by the integrated stress response (ISR)-related transcription factors ATF3 and ATF4. Here, we evaluate the role of the four eIF2α kinases, to decipher which is responsible for the mechanism of ISR activation triggered by fluorizoline in HeLa and HAP1 cells. First, we demonstrated the involvement of the eIF2α kinases using ISR inhibitor (ISRIB) and by simultaneous downregulation of all four eIF2α kinases, as both approaches were able to increase cell resistance to fluorizoline-induced apoptosis. Furthermore, we confirmed that fluorizoline treatment results in endoplasmic reticulum (ER) stress, as evidenced by PERK activation. Despite PERK activation, this kinase was not directly involved in the ISR activation by fluorizoline. In this regard, we found that the eIF2α kinases are capable of compensating for each other's loss of function. Importantly, we demonstrated that the mitochondrial-stress-related eIF2α kinase HRI mediates ISR activation after fluorizoline treatment.
Identifiants
pubmed: 37175767
pii: ijms24098064
doi: 10.3390/ijms24098064
pmc: PMC10179266
pii:
doi:
Substances chimiques
eIF-2 Kinase
EC 2.7.11.1
Prohibitins
0
Eukaryotic Initiation Factor-2
0
Activating Transcription Factor 4
145891-90-3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministerio de Ciencia e Innovación and ERDF
ID : PID2020-120537RB-I00
Organisme : Ministerio de Ciencia e Innovación and ERDF
ID : PID2019-107991RB-I00
Références
J Clin Invest. 2015 Jul 1;125(7):2592-608
pubmed: 26011642
Immunity. 2020 Apr 14;52(4):668-682.e7
pubmed: 32294407
Sci Rep. 2015 Jun 30;5:11781
pubmed: 26123823
Biochem Pharmacol. 2020 Oct;180:114198
pubmed: 32798467
Elife. 2015 Feb 26;4:
pubmed: 25719440
EMBO Rep. 2014 May;15(5):576-85
pubmed: 24719224
Oncotarget. 2017 Jul 19;8(44):76340-76356
pubmed: 29100316
Blood Cancer J. 2015 Dec 04;5:e373
pubmed: 26636288
Nature. 2009 Oct 8;461(7265):793-7
pubmed: 19812672
EMBO Mol Med. 2021 Apr 9;13(4):e12461
pubmed: 33665961
PLoS One. 2013 Oct 11;8(10):e77335
pubmed: 24146979
Genes Dev. 2008 Feb 15;22(4):476-88
pubmed: 18281461
Mol Pharmacol. 2022 Feb;101(2):78-86
pubmed: 34862308
FEBS J. 2016 Jul;283(14):2640-52
pubmed: 26587781
Chem Biol. 2013 Mar 21;20(3):316-31
pubmed: 23521790
Science. 2020 Apr 24;368(6489):
pubmed: 32327570
Oncotarget. 2015 Dec 8;6(39):41750-65
pubmed: 26497683
Cell Signal. 2014 Oct;26(10):2086-95
pubmed: 24975845
EMBO Rep. 2016 Oct;17(10):1374-1395
pubmed: 27629041
J Biol Chem. 2020 Jul 17;295(29):9855-9867
pubmed: 32430400
Elife. 2019 Jan 09;8:
pubmed: 30624206
Biochem J. 2015 Jan 15;465(2):213-25
pubmed: 25329545
Oncogene. 2017 Aug 17;36(33):4778-4789
pubmed: 28414306
Mol Biol Cell. 2005 Dec;16(12):5493-501
pubmed: 16176978
Trends Cell Biol. 2020 Jun;30(6):428-439
pubmed: 32413314
Elife. 2020 May 28;9:
pubmed: 32463360
Neoplasia. 2021 Aug;23(8):792-810
pubmed: 34246076
Biochem Biophys Res Commun. 2018 Oct 12;504(4):721-726
pubmed: 30217442
Biochim Biophys Acta. 2009 Jan;1793(1):27-32
pubmed: 18558096
PLoS Genet. 2012;8(6):e1002760
pubmed: 22719267
Cell. 2022 Sep 1;185(18):3356-3374.e22
pubmed: 36055199
Chem Biol. 2011 Jan 28;18(1):131-9
pubmed: 21276946
Oncotarget. 2016 Oct 4;7(40):64987-65000
pubmed: 27542247
Int J Mol Sci. 2022 Jan 25;23(3):
pubmed: 35163244
Int J Mol Sci. 2021 Jun 06;22(11):
pubmed: 34204139
J Med Chem. 2015 Feb 12;58(3):1426-41
pubmed: 25587754
Front Pharmacol. 2021 Sep 24;12:747837
pubmed: 34630117
Angew Chem Int Ed Engl. 2014 Sep 15;53(38):10150-4
pubmed: 25196378
Science. 2018 Mar 30;359(6383):1533-1536
pubmed: 29599245
Nature. 2020 Mar;579(7799):427-432
pubmed: 32132707
Cells. 2018 Nov 29;7(12):
pubmed: 30501123
Cell Death Dis. 2018 May 21;9(6):580
pubmed: 29784973
Curr Biol. 2017 Jul 10;27(13):R629-R631
pubmed: 28697355
Cells. 2019 Jan 18;8(1):
pubmed: 30669391
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
J Clin Invest. 2002 Nov;110(10):1383-8
pubmed: 12438433
Haematologica. 2017 Sep;102(9):1587-1593
pubmed: 28619845
Curr Opin Cell Biol. 2017 Aug;47:52-63
pubmed: 28391089
J Cell Biol. 2017 Jul 3;216(7):2027-2045
pubmed: 28566324
Cell Death Differ. 2012 Nov;19(11):1880-91
pubmed: 22705852
Bioorg Med Chem Lett. 2009 Dec 1;19(23):6548-51
pubmed: 19854648
Front Cell Dev Biol. 2020 Apr 22;8:274
pubmed: 32391361
Haematologica. 2018 Apr;103(4):e154-e157
pubmed: 29305413
Nature. 2020 Mar;579(7799):433-437
pubmed: 32132706
FEBS J. 2021 Feb;288(4):1271-1285
pubmed: 32648994
Biochem Biophys Res Commun. 2003 Aug 15;308(1):50-7
pubmed: 12890478